Ischaemic heart disease continues to be a major global public health challenge, highlighting the need for targeted interventions addressing modifiable risk factors.
Our results suggested that IHD remains a major public health challenge worldwide. More effective and targeted strategies aimed at implementing cost-effective interventions and addressing modifiable risk factors are urgently needed, particularly in geographies with high or increasing burden.
Dai et al. (2020) studied this question.